Viewing Study NCT04984356


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-01-01 @ 1:12 PM
Study NCT ID: NCT04984356
Status: COMPLETED
Last Update Posted: 2025-09-30
First Post: 2021-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL
Sponsor: Wugen, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module